Produkty 29702-25-8

CAS 29702-25-8 występuje w naszej ofercie pod nazwami: saponaretin/ 98.36% (existing batch purity), Isovitexin, ≥98%, ≥98%, Isovitexin. Oferty producentów: TargetMol, Chemat, GLPBio. Dostępne opakowania: 2mg, 5mg, 10mg, 25mg, 50mg, 100mg, 200mg, 20mg.

saponaretin/ 98.36% (existing batch purity)
TargetMol
  • opakowanie: 2mg, 5mg, 10mg, 25mg
  • Warianty: 7
od 392,86
Zobacz produkt
Isovitexin, ≥98%, ≥98%
Chemat
  • opakowanie: 20mg, 500mg, 5mg, 100mg
  • Warianty: 4
od 256,40
Zobacz produkt
Isovitexin
GLPBio
  • opakowanie: 20mg
  • Warianty: 1
od 1350,60
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one (CAS 29702-25-8) to związek chemiczny o wzorze sumarycznym C21H20O10 i masie molowej 432.4 g/mol. Nazwa systematyczna IUPAC: 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one. InChIKey: MYXNWGACZJSMBT-VJXVFPJBSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H20O10
Masa molowa432.4 g/mol
Nazwa IUPAC5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
InChIKeyMYXNWGACZJSMBT-VJXVFPJBSA-N
SMILESC1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C(=C3O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Isovitexin, Saponaretin, Homovitexin, Apigenin-6-C-glucoside, 6-Glucosylapigenin, 6-C-Glucosylapigenin, Apigenin 6-C-glucoside, 6-C-beta-D-Glucopyranosylapigenin, 6-glucosyl-apigenin, Isoavroside
Powiązane formy tego związku
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one C21H20O10
Izomery (ten sam wzór sumaryczny)
5,6-dihydroxy-2-phenyl-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one C21H20O10
1,6-dihydroxy-3-methyl-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyanthracene-9,10-dione C21H20O10
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one C21H20O10
5-hydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one C21H20O10
5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one C21H20O10
5-hydroxy-3-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one C21H20O10
1,3-dihydroxy-6-methyl-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyanthracene-9,10-dione C21H20O10
8-hydroxy-3-(hydroxymethyl)-1-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyanthracene-9,10-dione C21H20O10
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-phenylmethoxycarbonylbenzoyl)oxyoxane-2-carboxylic acid C21H20O10
5,7-dihydroxy-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one C21H20O10
3-(3,4-dihydroxyphenyl)-7-hydroxy-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one C21H20O10